Haemonetics Corporation Share Price
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:00:02 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 102.69 USD | +1.61% |
|
-0.22% | +28.12% |
| 08-19 | Barrington Raises Price Target on Haemonetics to $118 From $95, Keeps Outperform Rating | MT |
| 08-18 | Haemonetics Shares Rise After Signing Supply Agreement With CSL Plasma | MT |
| Market Cap | 4.67B 4.03B 3.81B 3.45B 6.48B 446B 6.51B 45.27B 17.41B 227B 17.55B 17.16B 718B | P/E 2027 * |
25.9x | P/E 2028 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.33B 4.6B 4.35B 3.94B 7.4B 510B 7.44B 51.68B 19.87B 259B 20.03B 19.59B 819B | EV / Sales 2027 * |
3.77x | EV / Sales 2028 * | 3.36x |
| Free-Float |
98.74% | Yield 2027 * |
0.97% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Boerse Muenchen
| HAZ | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Tradegate
| HAZ | Real-time |
Last Transcript : Haemonetics Corporation
| 1 day | +1.61% | ||
| 1 week | -0.22% | ||
| Current month | -0.37% | ||
| 1 month | +12.43% | ||
| 3 months | +31.32% | ||
| 6 months | +72.62% | ||
| Current year | +28.12% |
| 1 week | 100.53 |  | 103.52 |
| 1 month | 89.06 | | 109.57 |
| Current year | 51 | | 109.57 |
| 1 year | 47.32 | | 109.57 |
| 3 years | 47.32 | | 109.57 |
| 5 years | 43.5 | | 109.57 |
| 10 years | 32.76 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 15/05/2016 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 10/04/2022 |
Frank Chan
COO | Chief Operating Officer | 56 | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 31/12/2005 |
| Director/Board Member | 62 | 15/05/2016 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 17/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/07/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/07/26 | Free | Director | 2,538 | 0.0056% | ||
| 24/07/26 | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.61% | -0.22% | +96.72% | +14.15% | 4.67B | |
| -1.36% | -5.89% | -23.76% | -0.44% | 176B | |
| -0.72% | -3.41% | -3.26% | +12.32% | 116B | |
| +0.19% | -2.83% | +6.30% | +80.17% | 61.36B | |
| -1.92% | -6.01% | +7.05% | +38.44% | 49.42B | |
| +0.81% | -3.73% | -4.81% | -32.56% | 48.44B | |
| -1.75% | -5.54% | +8.93% | -20.82% | 31.33B | |
| +0.43% | -11.10% | - | - | 28.54B | |
| +0.58% | +1.84% | +36.58% | -12.08% | 24.37B | |
| +0.49% | -7.65% | -13.30% | +3.79% | 21.57B | |
| Average | -0.16% | -4.75% | +12.27% | +9.22% | 56.25B | |
| Weighted average by Cap. | -0.67% | -4.87% | -5.12% | +10.86% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.41B 1.22B 1.15B 1.05B 1.96B 135B 1.97B 13.71B 5.27B 68.77B 5.31B 5.2B 217B | 1.49B 1.28B 1.21B 1.1B 2.07B 142B 2.08B 14.43B 5.55B 72.37B 5.59B 5.47B 229B |
| Net income | 177M 153M 145M 131M 246M 16.95B 247M 1.72B 661M 8.62B 666M 652M 27.25B | 207M 179M 169M 153M 287M 19.8B 289M 2.01B 772M 10.07B 778M 761M 31.83B |
| Net Debt | 662M 570M 540M 490M 918M 63.25B 923M 6.41B 2.47B 32.18B 2.49B 2.43B 102B | 327M 282M 267M 242M 454M 31.25B 456M 3.17B 1.22B 15.9B 1.23B 1.2B 50.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$102.69 | +1.61% | 458,308 |
| 10/09/26 | US$101.06 | -2.04% | 602,323 |
| 09/09/26 | US$103.16 | +0.31% | 612,215 |
| 08/09/26 | US$102.84 | -0.08% | 581,588 |
| 04/09/26 | US$102.92 | +0.07% | 425,087 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
